GFAP and type 1 diabetes mellitus: Treatment with EGCG did not remarkably influence the GFAP immunoreactivity (Figure 5(b), P > 0.05, n = 5) but diminished Iba-1+ microglia in the SDH of T1DM mice on D14 (Figures 7(c) and 7(d), P < 0.01 or P < 0.001, n = 5).